Sort by:

Bolli E, Wirapati P, Hicham M, Xie Y, Siwicki M, Duval F, Goubet AG, Kiss M, Zitti B, Zwahlen T, Mcdowell S, Bill R, Angerani S, Engblom C, Anderson S, Jiang A, Hartley O, Sykes DB, Jankovic M, Fournier N, Gunzer M, Tarussio D, Tissot S, Sadow PM, Faquin WC, Sade-Feldman M, Weissleder R, Pai S, Mercier F, Manguso R, Pittet MJ

CCL3 is produced by aged neutrophils across cancers and promotes tumor growth.
Cancer Cell. 2026;44(3):624-640.e12 - PMID: 41650972 - PMCID: PMC13179570 - DOI: 10.1016/j.ccell.2026.01.006

Kim HS, Oh J, Jeon J, Fei F, Parvanian S, Kohler R, Garris C, Weissleder R

A ribonucleotide carbohydrate system (iRNC) enhances antigen presentation and controls glioblastoma.
Theranostics. 2026;16(8):3912-3927 - PMID: 41695470 - PMCID: PMC12905671 - DOI: 10.7150/thno.127558

Nguyen YTM, Pfefferlé M, Oh J, Simpson GG, Walker SA, Noguchi S, Garris CS, Deutsch-Williams RJ, Wirapati P, De Stefano F, Goemans M, Dai R, Vinegoni C, Fernández Del Castillo C, Liss AS, Pittet MJ, Weissleder R

Driving tumor-associated macrophages to a CXCL9Hi/SPP1Low phenotype eliminates pancreatic cancer.
Cell Rep Med. 2026;:102938 - PMID: 42492520 - DOI: 10.1016/j.xcrm.2026.102938
3 CSV